Floatz logo

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE

Headache

University Health Network, TorontoSmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Headache cohort.

Asset / SponsorPhaseRating
Topamax
University of Minnesota
Phase 4BBB
Treximet®
Danish Headache Center
Phase 4BBB
LIDOCAINE
Daniel A Tonetti, MD
Phase 4BBB
Prochlorperazine
Wake Forest University Health Sciences
Phase 4BBB
PROPOFOL
Medical College of Wisconsin
Phase 4BBB

View all 50 →

Same molecule, other indications

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE is also rated in:

major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →